This week's Hudson
seminar will be held Thursday 17 August 12pm-1pm in Seminar Rooms 1 & 2,
Level 2, TRF Building.
Our
speaker will be Dr David Godler, Group Leader and Senior Research
Fellow, Cyto-Molecular Diagnostics Research Group, Murdoch Children's Research Institute.
Dr Godler leads the Cyto-Molecular Diagnostics Research group at the Murdoch Children’s Research Institute, regularly publishing in high quality specialty journals such as Clinical Chemistry, Neurology, JAMA Neurology, Genetics in Medicine and Human Molecular Genetics. Using the clinical resources of the Victorian Clinical Genetics Services and those of national and international collaborators, his work focuses on understanding disorder aetiology and on test development for: improved diagnosis of chromosomal abnormalities, non-invasive prenatal testing and epigenetic disorders associated with intellectual disability and autism. Dr Godler also heads the world’s largest fragile X syndrome prevalence study in 100,000 newborns (NHMRC funded), and a Prader-Willi Syndrome newborn screening pilot to provide evidence regarding expanding current newborn screening in Australia and internationally. He is also the PI on DNA methylation studies, funded through national and international philanthropy, utilising droplet digital PCR to detect low level mosaicism missed by standard testing in developmental delay referrals of unknown cause.
A light lunch and refreshments will follow this presentation.
Please email shaunagh.mchugh@hudson.org.au if you would like to meet with David after the seminar.
No comments:
Post a Comment